Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Baldrich Esther Serra, Michihiro Hide et al.|The Lancet|2023Cited by 69
Current treatment practices and efficacy in solar urticaria: insights from a patient surveyLea Kiefer, Manuel P. Pereira, Felix Aulenbacher et al.|Frontiers in Immunology|2025Cited by 2